BCTX · BriaCell Therapeutics Corp. · Exempt Offerings
$3.50
+0.04 (+1.16%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“However, the Company's ability to continue as a going concern is dependent upon its ability to attain future profitable operations and to continue to obtain the necessary financing to meet its obligations arising from normal business operations when they come due. The uncertainty of the Company's ability to raise such financial capital casts substantial doubt on the Company's ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$31.54M
Shares
8.70M
Volume · Oct 21
24.7K
Avg daily vol (3M)
262.6K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.